609 related articles for article (PubMed ID: 22474743)
1. Risk of reoperation for mitral bioprosthesis dysfunction.
Jaussaud N; Gariboldi V; Grisoli D; Berbis J; Kerbaul F; Riberi A; Collart F
J Heart Valve Dis; 2012 Jan; 21(1):56-60. PubMed ID: 22474743
[TBL] [Abstract][Full Text] [Related]
2. Tricuspid valve replacement: bioprostheses are preferable.
Dalrymple-Hay MJ; Leung Y; Ohri SK; Haw MP; Ross JK; Livesey SA; Monro JL
J Heart Valve Dis; 1999 Nov; 8(6):644-8. PubMed ID: 10616242
[TBL] [Abstract][Full Text] [Related]
3. Short-term results of repeat valve replacement: a predictive factor analysis.
Beurtheret S; Gariboldi V; Feier H; Grisoli D; Riberi A; Mouly-Bandini A; Métras D; Kerbaul F; Collart F
J Heart Valve Dis; 2010 May; 19(3):326-32. PubMed ID: 20583395
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous aortic and mitral valve replacement: predictors of adverse outcome.
Kuwaki K; Tsukamoto M; Komatsu K; Morishita K; Sakata J; Abe T
J Heart Valve Dis; 2003 Mar; 12(2):169-76. PubMed ID: 12701788
[TBL] [Abstract][Full Text] [Related]
5. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients.
McClure RS; Narayanasamy N; Wiegerinck E; Lipsitz S; Maloney A; Byrne JG; Aranki SF; Couper GS; Cohn LH
Ann Thorac Surg; 2010 May; 89(5):1410-6. PubMed ID: 20417753
[TBL] [Abstract][Full Text] [Related]
6. Reoperation of left heart valve bioprostheses according to age at implantation.
Chan V; Malas T; Lapierre H; Boodhwani M; Lam BK; Rubens FD; Hendry PJ; Masters RG; Goldstein W; Mesana TG; Ruel M
Circulation; 2011 Sep; 124(11 Suppl):S75-80. PubMed ID: 21911822
[TBL] [Abstract][Full Text] [Related]
7. Risk of reoperation for aortic bioprosthesis dysfunction.
Jaussaud N; Gariboldi V; Giorgi R; Grisoli D; Chalvignac V; Thuny F; Riberi A; Collart F
J Heart Valve Dis; 2009 May; 18(3):256-61. PubMed ID: 19557979
[TBL] [Abstract][Full Text] [Related]
8. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
[TBL] [Abstract][Full Text] [Related]
9. Multiple valve replacement increases the risk of reoperation for structural degeneration of bioprostheses.
Caus T; Albertini JN; Chi Y; Collart F; Monties JR; Mesana T
J Heart Valve Dis; 1999 Jul; 8(4):376-83. PubMed ID: 10461236
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous aortic and mitral valve replacement in children: time-related outcomes and risk factors.
Alsoufi B; Al-Halees Z; Fadel B; Al-Wesabi A; Al-Ahmadi M; Joufan M; Siblini G; Canver CC
J Heart Valve Dis; 2010 May; 19(3):341-8. PubMed ID: 20583397
[TBL] [Abstract][Full Text] [Related]
11. Risk of repeat mitral valve replacement for failed mitral valve prostheses.
Potter DD; Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Schaff HV; Orszulak TA
Ann Thorac Surg; 2004 Jul; 78(1):67-72; discussion 67-72. PubMed ID: 15223405
[TBL] [Abstract][Full Text] [Related]
12. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
[TBL] [Abstract][Full Text] [Related]
13. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
14. Long-term results with the Xenomedica porcine bioprosthesis in the mitral position.
Santini F; Auriemma S; Casali G; Rossi A; Lusini M; Mazzucco A
J Heart Valve Dis; 2001 Nov; 10(6):789-94. PubMed ID: 11767188
[TBL] [Abstract][Full Text] [Related]
15. [Timing of reoperation of degenerated aortic and mitral bioprostheses].
Vogt PR; Brunner-LaRocca HP
Z Kardiol; 2001; 90 Suppl 6():70-4. PubMed ID: 11826825
[TBL] [Abstract][Full Text] [Related]
16. Eighteen-year follow up after Hancock II bioprosthesis insertion.
Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
[TBL] [Abstract][Full Text] [Related]
17. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome.
Alexiou C; Langley SM; Stafford H; Haw MP; Livesey SA; Monro JL
J Heart Valve Dis; 2000 May; 9(3):327-34. PubMed ID: 10888086
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of tricuspid valve replacement in the current era.
Filsoufi F; Anyanwu AC; Salzberg SP; Frankel T; Cohn LH; Adams DH
Ann Thorac Surg; 2005 Sep; 80(3):845-50. PubMed ID: 16122441
[TBL] [Abstract][Full Text] [Related]
20. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
